Neuroimaging in aging: brain maintenance [version 1; referees: 2 approved]

Neuroimaging in aging: brain maintenance [version 1; referees: 2 approved]

Neuroimaging studies of the aging brain provide support that the strongest predictor of preserved memory and cognition in older age is brain maintenance, or relative lack of brain pathology. Evidence for brain maintenance comes from different levels of examination, but up to now relatively few studi...

Full description

Bibliographic Details
Main Author:	Lars Nyberg
Format:	Article
Language:	English
Published:	F1000 Research Ltd 2017-07-01
Series:	F1000Research
Subjects:	Aging Cognitive Neuroscience Neurobiology of Disease & Regeneration Neuroimaging Neuronal & Glial Cell Biology Neuronal Signaling Mechanisms
Online Access:	https://f1000research.com/articles/6-1215/v1

Similar Items

Selective vulnerabilities and biomarkers in neurocognitive aging [version 1; referees: 4 approved]
by: Zachariah Reagh, et al.
Published: (2017-04-01)

Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease [version 1; referees: 3 approved]
by: Alana M. Horowitz, et al.
Published: (2017-08-01)

Monitoring ferumoxide-labelled neural progenitor cells and lesion evolution by magnetic resonance imaging in a model of cell transplantation in cerebral ischaemia [v1; ref status: indexed, http://f1000r.es/20l]
by: Rachael A Panizzo, et al.
Published: (2013-11-01)

Regulation of Microtubule Dynamics in Axon Regeneration: Insights from C. elegans [version 1; referees: 3 approved]
by: Ngang Heok Tang, et al.
Published: (2016-04-01)

Super resolution microscopy is poised to reveal new insights into the formation and maturation of dendritic spines [version 1; referees: 2 approved]
by: Cristina M. Robinson, et al.
Published: (2016-06-01)

Non-ionotropic signaling by the NMDA receptor: controversy and opportunity [version 1; referees: 2 approved]
by: John A. Gray, et al.
Published: (2016-05-01)

Disinhibition, an emerging pharmacology of learning and memory [version 1; referees: 3 approved]
by: Hanns Möhler, et al.
Published: (2017-02-01)

The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system? [version 1; referees: 2 approved]
by: Norman R. Saunders, et al.
Published: (2016-03-01)

Metals and Neurodegeneration [version 1; referees: 3 approved]
by: Pan Chen, et al.
Published: (2016-03-01)

Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury [v1; ref status: indexed, http://f1000r.es/2lf]
by: Laura Genis, et al.
Published: (2014-01-01)

Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury [v2; ref status: indexed, http://f1000r.es/38u]
by: Laura Genis, et al.
Published: (2014-04-01)

Extracellular histone H1 is neurotoxic and drives a pro-inflammatory response in microglia [v1; ref status: indexed, http://f1000r.es/18z]
by: Jonathan D Gilthorpe, et al.
Published: (2013-07-01)

Recent advances in hepatic encephalopathy [version 1; referees: 4 approved]
by: Victoria Liere, et al.
Published: (2017-09-01)

Eph-ephrin signaling in nervous system development [version 1; referees: 2 approved]
by: Karina S. Cramer, et al.
Published: (2016-03-01)

Neural repair in the adult brain [version 1; referees: 3 approved]
by: Sebastian Jessberger
Published: (2016-02-01)

Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective [version 1; referees: 2 approved]
by: Lara Hwa, et al.
Published: (2017-03-01)

Cannabinoid receptor type-1: breaking the dogmas [version 1; referees: 3 approved]
by: Arnau Busquets Garcia, et al.
Published: (2016-05-01)

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies [version 1; referees: 2 approved]
by: Rimona S. Weil, et al.
Published: (2017-08-01)

Recent advances in understanding neurotrophin signaling [version 1; referees: 2 approved]
by: Mark Bothwell
Published: (2016-07-01)

Progress toward an integrated understanding of Parkinson's disease [version 1; referees: 2 approved]
by: Maxime W.C. Rousseaux, et al.
Published: (2017-07-01)

New insights into cochlear sound encoding [version 1; referees: 2 approved]
by: Tobias Moser, et al.
Published: (2016-08-01)

Recent advances in treating Parkinson’s disease [version 1; referees: 2 approved]
by: Wolfgang H. Oertel
Published: (2017-03-01)

Rehabilitation following hemorrhagic stroke: building the case for stroke-subtype specific recovery therapies [version 1; referees: 2 approved]
by: Tomoko Kitago, et al.
Published: (2017-11-01)

Contemporary views on inflammatory pain mechanisms: TRPing over innate and microglial pathways [version 1; referees: 3 approved]
by: Zhonghui Guan, et al.
Published: (2016-09-01)

Intracerebral haemorrhage in Down syndrome: protected or predisposed? [version 1; referees: 2 approved]
by: Lewis Buss, et al.
Published: (2016-05-01)

Transporting mitochondria in neurons [version 1; referees: 2 approved]
by: Meredith M. Course, et al.
Published: (2016-07-01)

Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism [version 1; referees: 2 approved]
by: Vladimir N. Uversky
Published: (2017-04-01)

Pathophysiological links between traumatic brain injury and post-traumatic headaches [version 1; referees: 3 approved]
by: Robert L. Ruff, et al.
Published: (2016-08-01)

CNS cell-type localization and LPS response of TLR signaling pathways [version 1; referees: 2 approved]
by: Gizelle M. McCarthy, et al.
Published: (2017-07-01)

Dynamical systems, attractors, and neural circuits [version 1; referees: 3 approved]
by: Paul Miller
Published: (2016-05-01)

West Nile Virus Infection in the Central Nervous System [version 1; referees: 3 approved]
by: Evandro R. Winkelmann, et al.
Published: (2016-01-01)

Glucocorticoid receptor action in metabolic and neuronal function [version 1; referees: 3 approved]
by: Michael J. Garabedian, et al.
Published: (2017-07-01)

Nigrostriatal dynein changes in A53T alpha-synuclein transgenic mice [v1; ref status: indexed, http://f1000r.es/2wb]
by: Yan Liu, et al.
Published: (2014-03-01)

Multiple system atrophy: genetic risks and alpha-synuclein mutations [version 1; referees: 2 approved]
by: Heather T Whittaker, et al.
Published: (2017-11-01)

New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND) [version 1; referees: 3 approved]
by: Tanjala T. Gipson, et al.
Published: (2017-06-01)

New drugs in psychiatry: focus on new pharmacological targets [version 1; referees: 3 approved]
by: Filippo Caraci, et al.
Published: (2017-03-01)

Experimental autoimmune encephalomyelitis from a tissue energy perspective [version 1; referees: 2 approved]
by: Roshni A Desai, et al.
Published: (2017-11-01)

Linking cortical microtubule attachment and exocytosis [version 1; referees: 2 approved]
by: Ivar Noordstra, et al.
Published: (2017-04-01)

Learning intrinsic excitability in medium spiny neurons [v2; ref status: indexed, http://f1000r.es/30b]
by: Gabriele Scheler
Published: (2014-02-01)

Neurosharing: large-scale data sets (spike, LFP) recorded from the hippocampal-entorhinal system in behaving rats [v1; ref status: indexed, http://f1000r.es/37v]
by: Kenji Mizuseki, et al.
Published: (2014-04-01)